Your browser doesn't support javascript.
loading
Correction to: Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
Gupta, Anuradha; Sharma, Deepak; Meena, Jairam; Pandya, Sanketkumar; Sachan, Madhur; Kuma, Sadan; Singh, Kavita; Mitra, Kalyan; Sharma, Sharad; Panda, Amulya K; Gupta, Pushpa; Gupta, Umesh Datta; Misra, Amit.
Afiliación
  • Gupta A; Pharmaceutics Division, CSIR-Central Drug Research Institute, Sector 10A, Jankipuram Extension, Lucknow, 226031, India.
  • Sharma D; Pharmaceutics Division, CSIR-Central Drug Research Institute, Sector 10A, Jankipuram Extension, Lucknow, 226031, India.
  • Meena J; National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Pandya S; Pharmaceutics Division, CSIR-Central Drug Research Institute, Sector 10A, Jankipuram Extension, Lucknow, 226031, India.
  • Sachan M; Pharmaceutics Division, CSIR-Central Drug Research Institute, Sector 10A, Jankipuram Extension, Lucknow, 226031, India.
  • Kuma S; Pharmaceutics Division, CSIR-Central Drug Research Institute, Sector 10A, Jankipuram Extension, Lucknow, 226031, India.
  • Singh K; Pharmaceutics Division, CSIR-Central Drug Research Institute, Sector 10A, Jankipuram Extension, Lucknow, 226031, India.
  • Mitra K; Pharmaceutics Division, CSIR-Central Drug Research Institute, Sector 10A, Jankipuram Extension, Lucknow, 226031, India.
  • Sharma S; Pharmaceutics Division, CSIR-Central Drug Research Institute, Sector 10A, Jankipuram Extension, Lucknow, 226031, India.
  • Panda AK; National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Gupta P; National JALMA Institute for Leprosy and Other Mycobacterial Diseases, ICMR, Tajganj, Agra, 282001, India.
  • Gupta UD; National JALMA Institute for Leprosy and Other Mycobacterial Diseases, ICMR, Tajganj, Agra, 282001, India.
  • Misra A; Pharmaceutics Division, CSIR-Central Drug Research Institute, Sector 10A, Jankipuram Extension, Lucknow, 226031, India. amit_misra@cdri.res.in.
Pharm Res ; 39(5): 1027-1028, 2022 May.
Article en En | MEDLINE | ID: mdl-35438447

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharm Res Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharm Res Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos